Ginseng extracts restore high-glucose induced vascular dysfunctions by altering triglyceride metabolism and downregulation of atherosclerosis-related genes

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Chan, Gabriel Hoi Huen ^a   Law, Betty Yuen Kwan ^a,b   Chu, John Man Tak ^a   Yue, Kevin Kin Man ^a   Jiang, Zhi Hong ^a   Lau, Chi Wai ^c   Huang, Yu ^c   Chan, Shun Wan ^d   Ying Kit Yue, Patrick ^a   Wong, Ricky Ngok Shun ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^b MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; APOLIPOPROTEIN E; CELL ADHESION MOLECULE; CHOLESTEROL; CXCL1 CHEMOKINE; FIBRONECTIN; GINSENG EXTRACT; GLUCOSE; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; HIGH DENSITY LIPOPROTEIN; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR TYPE II; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SECONDARY LYMPHOID TISSUE CHEMOKINE; SELECTIN; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; TUMOR NECROSIS FACTOR ALPHA; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BODY WEIGHT; CELL GROWTH; CELL MIGRATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DOWN REGULATION; ENDOTHELIAL DYSFUNCTION; GENE; GENE EXPRESSION; GINSENG; GLUCOSE BLOOD LEVEL; GLUCOSE INTAKE; INSULIN BLOOD LEVEL; INTRAABDOMINAL FAT; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MACROPHAGE ACTIVATION; MALE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR DISEASE; VASODILATATION;

EID: 84886655022     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/797310     Document Type: Article

References (37)

1. Lü J.-M., Yao Q., Chen C., Ginseng compounds: an update on their molecular mechanisms and medical applications. Current Vascular Pharmacology 2009 7 3 293 302 2-s2.0-69149110615 10.2174/157016109788340767
2. Karmazyn M., Moey M., Gan X. T., Therapeutic potential of ginseng in the management of cardiovascular disorders. Drugs 2011 71 15 1989 2008 2-s2.0-80053953131 10.2165/11594300-000000000-00000
3. Ross R., Glomset J. A., The pathogenesis of atherosclerosis. New England Journal of Medicine 1976 295 7 369 377 2-s2.0-0017305294
4. Furchgott R. F., Zawadzki J. V., The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980 288 5789 373 376 2-s2.0-0019195506 (Pubitemid 11169009)
5. Faggiotto A., Ross R., Harker L., Studies of hypercholesterolemia in the nonhuman primate-I. Changes that lead to fatty streak formation. Arteriosclerosis 1984 4 4 323 340 2-s2.0-0021261107 (Pubitemid 14092676)
6. Hansson G. K., Hermansson A., The immune system in atherosclerosis. Nature Immunology 2011 12 3 204 212 2-s2.0-79951669207 10.1038/ni.2001
7. Libby P., Ridker P. M., Hansson G. K., Progress and challenges in translating the biology of atherosclerosis. Nature 2011 473 7347 317 325 2-s2.0-79956319051 10.1038/nature10146
8. Kuo H.-K., Wu P.-C., Kuo C.-N., Chen Y.-H., Effect of insulin on the expression of intraocular vascular endothelial growth factor in diabetic rats. Chang Gung Medical Journal 2006 29 6 555 560 2-s2.0-33847011315
9. Zhu G.-Y., Li Y.-W., Hau D. K.-P., Jiang Z.-H., Yu Z.-L., Fong W.-F., Protopanaxatriol-type ginsenosides from the root of Panax ginseng. Journal of Agricultural and Food Chemistry 2011 59 1 200 205 2-s2.0-78651107135 10.1021/jf1037932
10. Chan G. H. H., Fiscus R. R., Severe impairment of CGRP-induced hypotension in vivo and vasorelaxation in vitro in elderly rats. European Journal of Pharmacology 2002 434 3 133 139 2-s2.0-0037059491 10.1016/S0014-2999(01)01545-X (Pubitemid 34056572)
11. Rubanyi G. M., Endothelium-derived relaxing and contracting factors. Journal of Cellular Biochemistry 1991 46 1 27 36 2-s2.0-0025804983
12. De Vriese A. S., Verbeuren T. J., Van De Voorde J., Lameire N. H., Vanhoutte P. M., Endothelial dysfunction in diabetes. British Journal of Pharmacology 2000 130 5 963 974 2-s2.0-0033920419 (Pubitemid 30453529)
13. Leo C. H., Hart J. L., Woodman O. L., Impairment of both nitric oxide-mediated and EDHF-type relaxation in small mesenteric arteries from rats with streptozotocin-induced diabetes. British Journal of Pharmacology 2011 162 2 365 377 2-s2.0-78650391731 10.1111/j.1476-5381.2010.01023.x
14. Taguchi K., Kobayashi T., Matsumoto T., Kamata K., Dysfunction of endothelium-dependent relaxation to insulin via PKC-mediated GRK2/Akt activation in aortas of ob/ob mice. American Journal of Physiology: Heart and Circulatory Physiology 2011 301 2 H571 H583 2-s2.0-79961038726 10.1152/ajpheart.01189.2010
15. Linden E., Cai W., He J. C., Xue C., Li Z., Winston J., Vlassara H., Uribarri J., Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation. Clinical Journal of the American Society of Nephrology 2008 3 3 691 698 2-s2.0-44649098371 10.2215/CJN.04291007
16. Atochin D. N., Huang P. L., Endothelial nitric oxide synthase transgenic models of endothelial dysfunction. Pflugers Archiv European Journal of Physiology 2010 460 6 965 974 2-s2.0-78549291345 10.1007/s00424-010-0867-4
17. Yamagishi S.-I., Matsui T., Advanced glycation end products, oxidative stress and diabetic nephropathy. Oxidative Medicine and Cellular Longevity 2010 3 2 101 108 2-s2.0-77953729130 10.4161/oxim.3.2.11148
18. Hegab Z., Gibbons S., Neyses L., Mamas M. A., Role of advanced glycation end products in cardiovascular disease. World Journal of Cardiology 2012 4 4 90 102
19. Schalkwijk C. G., Miyata T., Early- and advanced non-enzymatic glycation in diabetic vascular complications: the search for therapeutics. Amino Acids 2012 42 4 1193 1204 2-s2.0-77957928645 10.1007/s00726-010-0779-9
20. Liao J. K., Endothelium and acute coronary syndromes. Clinical Chemistry 1998 44 8 1799 1808 2-s2.0-0031848134 (Pubitemid 28368900)
21. Mertens A. N. N., Holvoet P., Oxidized LDL and HDL: antagonists in atherothrombosis. FASEB Journal 2001 15 12 2073 2084 2-s2.0-0034804981 10.1096/fj.01-0273rev (Pubitemid 32927925)
22. Faries P. L., Rohan D. I., Wyers M. C., Marin M. L., Hollier L. H., Quist W. C., LoGerfo F. W., Vascular smooth muscle cells derived from atherosclerotic human arteries exhibit greater adhesion, migration, and proliferation than venous cells. Journal of Surgical Research 2002 104 1 22 28 2-s2.0-0036343623 10.1006/jsre.2002.6399 (Pubitemid 34948328)
23. Rossetti L., Goldberg I. J., A new piece in the diabetes puzzle. Nature Medicine 2002 8 2 112 114 2-s2.0-0036174568 10.1038/nm0202-112 (Pubitemid 34155118)
24. Hosoyamada K., Uto H., Imamura Y., Fatty liver in men is associated with high serum levels of small, dense low-density lipoprotein cholesterol. Diabetology & Metabolic Syndrome 2012 4 1, article 34
25. Liu L., Aboud O., Jones R. A., Mrak R. E., Griffin W. S. T., Barger S. W., Apolipoprotein E expression is elevated by interleukin 1 and other interleukin 1-induced factors. Journal of Neuroinflammation 2011 8, article 175 2-s2.0-83455213559 10.1186/1742-2094-8-175
26. Jansen H. J., Vervoort G., Van der Graaf M., Tack C. J., Pronounced weight gain in insulin-treated patients with type 2 diabetes mellitus is associated with an unfavourable cardiometabolic risk profle. Netherlands Journal of Medicine 2010 68 11 359 366 2-s2.0-78649787845
27. Adams L., Hane S., Adrenal gland size as an index of adrenocortical secretion rate in the California ground squirrel. Journal of Wildlife Diseases 1972 8 1 19 23 2-s2.0-0015263943
28. Du Ruisseau P., Taché Y., Selye H., Effects of chronic stress on pituitary hormone release induced by combined hemi extirpation of the thyroid, adrenal and ovary in rats. Neuroendocrinology 1977 24 3-4 169 182 2-s2.0-0017593042 (Pubitemid 8279361)
29. Naeser P., Adrenal function in the diabetic mutant mouse (gene symbol dbm). Acta Physiologica Scandinavica 1976 98 4 395 399 2-s2.0-0017107734
30. Durand E., Scoazec A., Lafont A., Boddaert J., Al Hajzen A., Addad F., Mirshahi M., Desnos M., Tedgui A., Mallat Z., In vivo induction of endothelial apoptosis leads to vessel thrombosis and endothelial denudation: a clue to the understanding of the mechanisms of thrombotic plaque erosion. Circulation 2004 109 21 2503 2506 2-s2.0-2642585697 10.1161/01.CIR.0000130172.62481.90 (Pubitemid 38720547)
31. Fuster V., Fayad Z. A., Badimon J. J., Acute coronary syndromes: biology. The Lancet 1999 353 2 5 9 2-s2.0-0033549388
32. Ebbert J. O., Jensen M. D., Fat depots, free fatty acids, and dyslipidemia. Nutrients 2013 5 2 498 508
33. Shang W., Yang Y., Jiang B., Jin H., Zhou L., Liu S., Chen M., Ginsenoside Rb1 promotes adipogenesis in 3T3-L1 cells by enhancing PPAR γ 2 and C/EBP α gene expression. Life Sciences 2007 80 7 618 625 2-s2.0-33846064201 10.1016/j.lfs.2006.10.021 (Pubitemid 46074052)
34. Liu Z., Li W., Li X., Antidiabetic effects of malonyl ginsenosides from Panax ginseng on type 2 diabetic rats induced by high-fat diet and streptozotocin. Journal of Ethnopharmacology 2013 145 1 233 240
35. Dominiczak M. H., Obesity, glucose intolerance and diabetes and their links to cardiovascular disease. Implications for laboratory medicine. Clinical Chemistry and Laboratory Medicine 2003 41 9 1266 1278 2-s2.0-0142093106 10.1515/CCLM.2003.194 (Pubitemid 37265709)
36. Brownlee M., The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005 54 6 1615 1625 2-s2.0-20044376702 10.2337/diabetes.54. 6.1615 (Pubitemid 40770750)
37. Charo I. F., Taub R., Anti-inflammatory therapeutics for the treatment of atherosclerosis. Nature Reviews Drug Discovery 2011 10 5 365 376 2-s2.0-79955604190 10.1038/nrd3444